• 15863 Citations
  • 73 h-Index
19952020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Review article
2020

Targeting of G-protein coupled receptors in sepsis

Rehman, A., Baloch, N. U. A., Morrow, J. P., Pacher, P. & Haskó, G., jan. 1 2020, (Accepted/In press) In : Pharmacology and Therapeutics. 107529.

Research output: Review article

2019

Adenosine signaling and the immune system: When a lot could be too much

Antonioli, L., Fornai, M., Blandizzi, C., Pacher, P. & Haskó, G., jan. 2019, In : Immunology letters. 205, p. 9-15 7 p.

Research output: Review article

18 Citations (Scopus)

P2X4 receptors, immunity, and sepsis

Antonioli, L., Blandizzi, C., Fornai, M., Pacher, P., Lee, H. T. & Haskó, G., aug. 2019, In : Current Opinion in Pharmacology. 47, p. 65-74 10 p.

Research output: Review article

3 Citations (Scopus)

Rethinking Communication in the Immune System: The Quorum Sensing Concept

Antonioli, L., Blandizzi, C., Pacher, P., Guilliams, M. & Haskó, G., febr. 2019, In : Trends in Immunology. 40, 2, p. 88-97 10 p.

Research output: Review article

6 Citations (Scopus)
2018

Adenosine metabolism, immunity and joint health

Haskó, G., Antonioli, L. & Cronstein, B. N., máj. 2018, In : Biochemical Pharmacology. 151, p. 307-313 7 p.

Research output: Review article

13 Citations (Scopus)

Cardiovascular effects of marijuana and synthetic cannabinoids: The good, the bad, and the ugly

Pacher, P., Steffens, S., Haskó, G., Schindler, T. H. & Kunos, G., márc. 1 2018, In : Nature Reviews Cardiology. 15, 3, p. 151-166 16 p.

Research output: Review article

74 Citations (Scopus)

Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases

Berger, N. A., Besson, V. C., Boulares, A. H., Bürkle, A., Chiarugi, A., Clark, R. S., Curtin, N. J., Cuzzocrea, S., Dawson, T. M., Dawson, V. L., Haskó, G., Liaudet, L., Moroni, F., Pacher, P., Radermacher, P., Salzman, A. L., Snyder, S. H., Soriano, F. G., Strosznajder, R. P., Sümegi, B. & 2 others, Swanson, R. A. & Szabo, C., jan. 1 2018, In : British journal of pharmacology. 175, 2, p. 192-222 31 p.

Research output: Review article

58 Citations (Scopus)
2017

Switching off CD73: a way to boost the activity of conventional and targeted antineoplastic therapies

Antonioli, L., Novitskiy, S. V., Sachsenmeier, K. F., Fornai, M., Blandizzi, C. & Haskó, G., nov. 1 2017, In : Drug Discovery Today. 22, 11, p. 1686-1696 11 p.

Research output: Review article

30 Citations (Scopus)
2016

Anti-CD73 in Cancer Immunotherapy: Awakening New Opportunities

Antonioli, L., Yegutkin, G. G., Pacher, P., Blandizzi, C. & Haskó, G., febr. 1 2016, In : Trends in Cancer. 2, 2, p. 95-109 15 p.

Research output: Review article

87 Citations (Scopus)
2015

Adenosine signalling in diabetes mellitus-pathophysiology and therapeutic considerations

Antonioli, L., Blandizzi, C., Csóka, B., Pacher, P. & Haskó, G., ápr. 30 2015, In : Nature Reviews Endocrinology. 11, 4, p. 228-241 14 p.

Research output: Review article

75 Citations (Scopus)
158 Citations (Scopus)
2014

Adenosine and inflammation: What's new on the horizon?

Antonioli, L., Csóka, B., Fornai, M., Colucci, R., Kókai, E., Blandizzi, C. & Haskó, G., aug. 2014, In : Drug Discovery Today. 19, 8, p. 1051-1068 18 p.

Research output: Review article

82 Citations (Scopus)

Adenosine pathway and cancer: Where do we go from here?

Antonioli, L., Haskó, G., Fornai, M., Colucci, R. & Blandizzi, C., szept. 2014, In : Expert Opinion on Therapeutic Targets. 18, 9, p. 973-977 5 p.

Research output: Review article

13 Citations (Scopus)
2013

CD39 and CD73 in immunity and inflammation

Antonioli, L., Pacher, P., Vizi, E. S. & Haskó, G., jún. 1 2013, In : Trends in Molecular Medicine. 19, 6, p. 355-367 13 p.

Research output: Review article

424 Citations (Scopus)

Immunity, inflammation and cancer: A leading role for adenosine

Antonioli, L., Blandizzi, C., Pacher, P. & Haskó, G., nov. 14 2013, In : Nature Reviews Cancer. 13, 12, p. 842-857 16 p.

Research output: Review article

334 Citations (Scopus)
2012

The endocannabinoid system and plant-derived cannabinoids in diabetes and diabetic complications

Horvth, B., Mukhopadhyay, P., Hask, G. & Pacher, P., febr. 1 2012, In : American Journal of Pathology. 180, 2, p. 432-442 11 p.

Research output: Review article

76 Citations (Scopus)
2011

Investigational A3 adenosine receptor targeting agents

Koscsó, B., Csóka, B., Pacher, P. & Haskó, G., jún. 1 2011, In : Expert Opinion on Investigational Drugs. 20, 6, p. 757-768 12 p.

Research output: Review article

22 Citations (Scopus)
2009

A2B adenosine receptors in immunity and inflammation

Haskó, G., Csóka, B., Németh, Z. H., Vizi, E. S. & Pacher, P., jún. 1 2009, In : Trends in Immunology. 30, 6, p. 263-270 8 p.

Research output: Review article

147 Citations (Scopus)

HIF-1: A key mediator in hypoxia (Review)

Adams, J. M., Difazio, L. T., Rolandelli, R. H., Luján, J. J., Haskó, G., Csóka, B., Selmeczy, Z. & Németh, Z. H., márc. 13 2009, In : Acta physiologica Hungarica. 96, 1, p. 19-28 10 p.

Research output: Review article

97 Citations (Scopus)

The endocannabinoid system of the skin in health and disease: novel perspectives and therapeutic opportunities

Bíró, T., Tóth, B. I., Haskó, G., Paus, R. & Pacher, P., aug. 1 2009, In : Trends in Pharmacological Sciences. 30, 8, p. 411-420 10 p.

Research output: Review article

122 Citations (Scopus)
2008

Adenosine receptors: Therapeutic aspects for inflammatory and immune diseases

Haskó, G., Linden, J., Cronstein, B. & Pacher, P., szept. 10 2008, In : Nature Reviews Drug Discovery. 7, 9, p. 759-770 12 p.

Research output: Review article

718 Citations (Scopus)
159 Citations (Scopus)
2007

Shaping of monocyte and macrophage function by adenosine receptors

Haskó, G., Pacher, P., Deitch, E. A. & Vizi, E. S., febr. 1 2007, In : Pharmacology and Therapeutics. 113, 2, p. 264-275 12 p.

Research output: Review article

145 Citations (Scopus)
2006

NO-independent stimulators and activators of soluble guanylate cyclase: Discovery and therapeutic potential

Evgenov, O. V., Pacher, P., Schmidt, P. M., Haskó, G., Schmidt, H. H. H. W. & Stasch, J. P., szept. 1 2006, In : Nature Reviews Drug Discovery. 5, 9, p. 755-768 14 p.

Research output: Review article

487 Citations (Scopus)
2005

Adenosine receptor signaling in the brain immune system

Haskó, G., Pacher, P., Vizi, E. S. & Illes, P., okt. 1 2005, In : Trends in Pharmacological Sciences. 26, 10, p. 511-516 6 p.

Research output: Review article

144 Citations (Scopus)
2004

Adenosine: An endogenous regulator of innate immunity

Haskó, G. & Cronstein, B. N., jan. 2004, In : Trends in Immunology. 25, 1, p. 33-39 7 p.

Research output: Review article

642 Citations (Scopus)

Immunomodulatory and neuroprotective effects of inosine

Haskó, G., Sitkovsky, M. V. & Szabó, C., márc. 2004, In : Trends in Pharmacological Sciences. 25, 3, p. 152-157 6 p.

Research output: Review article

178 Citations (Scopus)
2002

Adenosine: A potential mediator of immunosuppression in multiple organ failure

Haskó, G., Deitch, E. A., Szabó, C., Németh, Z. H. & Vizi, E. S., aug. 1 2002, In : Current Opinion in Pharmacology. 2, 4, p. 440-444 5 p.

Research output: Review article

57 Citations (Scopus)
1999
42 Citations (Scopus)
53 Citations (Scopus)
1996

Cytokine production and its manipulation by vasoactive drugs

Pastores, S. M., Hasko, G., Vizi, E. S. & Kvetan, V., jún. 18 1996, In : New Horizons: Science and Practice of Acute Medicine. 4, 2, p. 252-264 13 p.

Research output: Review article

53 Citations (Scopus)